• SENSEX 79,454.47
    -880.34 (--1.10%)
  • BANKNIFTY 53,595.25
    -770.40 (--1.42%)
  • TVS Holdings
    8,818.25 7,755.00(%)
  • Angel One
    2,253.00 1,942.00(%)
  • Mazagon Dock
    2,962.90 3,170.00(%)
  • Tata Motors
    710.85 1,179.05(%)
  • Nuvama Wealth
    6,031.50 7,647.95(%)
  • Bharat Dynamics
    1,595.00 1,794.70(%)
  • Yes Bank
    20.36 27.41(%)
  • Bharat Electron
    321.80 340.35(%)
  • Paras Defence
    1,476.00 1,592.75(%)
  • Larsen & Toubro
    3,477.55 3,963.00(%)
  • Cochin Shipyard
    1,491.70 2,977.10(%)
  • Suzlon Energy
    50.96 37.95(%)
  • Jio Financial
    242.15 198.60(%)
  • Apollo Micro Sys
    137.00 157.00(%)
  • Titan Company
    3,530.00 3,866.15(%)
  • Hind.Aeronautics
    4,578.95 5,675.00(%)
  • Reliance Industr
    1,372.05 1,115.55(%)
  • Adani Green
    854.50 758.00(%)
  • Canara Bank
    98.40 129.35(%)
  • Dixon Technolog.
    15,063.05 7,935.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lactose (India) Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Toshniwal
  • BSE Code : 2283.0
  • ISIN : INE058I01013
103.45 -2 (-1.99%)
  • As on 09 May 2025 (EOD)

  • Today’s Low

    103.45

  • Today’s High

    103.45

  • Open

    103.45

  • Perv Close

    105.55

  • 52W Low

    84.27

  • 52W High

    247.40

Key Indicators

  • P/E(TTM)

    21.07

  • Mar.Cap (₹Cr.)

    145.75

  • Div & Yield %

    0.00

  • Book Value(₹)

    55.01

  • Debt-Equity Ratio

    -1.99

  • AGM Date

    09-May-2025

  • EPS

    4.91

  • P/E Ratio

    21.07

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    145.75

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    14.09

  • BV (₹)

    55.00

  • Sales( ₹ in Cr.)

    113.89

  • NP (in Cr.)

    6.78

  • NP Var(%)

    471.0

  • Div%

    0.0

  • CPS (₹)

    8.50

  • EPS (₹)

    4.80

  • Traded Value (₹ in Lakhs)

    148.71

  • 52 Week High

    247.40

  • 52 Week Low

    84.27

  • Price BSE

    106.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    148.71

  • P/C Ratio

    12.40

  • P/E Ratio

    22.00

  • Price Vs.BV

    4.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 113.89 65.80 45.94 34.96 40.05 40.61
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 113.89 65.80 45.94 34.96 40.05 40.61
Other Income 1.12 0.72 0.58 0.31 0.30 0.42
Stock Adjustments -2.70 11.31 -0.40 -0.52 0.14 -0.01
Total Income 112.31 77.83 46.12 34.75 40.49 41.02
EXPENDITURE :            
Raw Materials 48.86 35.50 7.18 4.65 7.04 7.70
Power and Fuel Cost 9.69 7.09 6.89 5.84 6.30 6.24
Employee Cost 8.72 6.57 12.25 10.63 11.88 11.17
Other Manufacturing Expenses 13.76 10.11 1.98 1.64 1.34 1.31
Selling and Administration Expenses 8.65 4.28 2.89 2.80 2.50 2.90
Miscellaneous Expenses 2.52 2.18 2.08 2.65 1.87 1.67
Employee Benefit Expenses 8.72 6.57 12.25 10.63 11.88 11.17
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 92.19 65.74 33.28 28.22 30.92 30.99
Operating Profit 20.12 12.10 12.85 6.54 9.57 10.03
Interest 5.24 5.95 5.12 5.45 5.56 5.35
Gross Profit 14.88 6.15 7.73 1.09 4.01 4.68
Depreciation 5.22 4.69 4.56 4.36 3.91 3.60
Profit Before Tax 9.66 1.46 3.17 -3.27 0.10 1.08
Current Tax 1.57 0.18 0.57 0.05 0.02 0.21
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.31 0.08 0.15 -0.84 0.01 0.15
Reported Net Profit 6.79 1.21 2.45 -2.48 0.07 0.72
Extraordinary Items 0.01 0.02 0.03 0.00 0.00 0.04
Adjusted Net Profit 6.78 1.19 2.42 -2.48 0.07 0.68
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 14.05 12.84 10.39 12.87 12.80 12.08
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 20.84 14.05 12.84 10.39 12.87 12.80
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 5.39 0.96 1.95 -2.17 0.07 0.71
Earnings Per Share(Adj)-Unit Curr 5.39 0.96 1.95 -2.17 0.07 0.71
Book Value 37.41 32.22 31.21 30.15 33.65 33.61
Book Value(Adj)-Unit Curr 37.41 32.22 31.21 30.15 33.65 33.61

Shareholding Pattern

  • Promoter Group

    53.65%

  • Public Share Holding

    46.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 575,184 4.57 575,184 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 750,000 5.96 750,000 1
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,428,242 43.12 5,428,242 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,753,426 53.65 6,753,426 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 77,920 0.62 0 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 77,920 0.62 0 4
2] Non Institution
Bodies Corporate 774,899 6.16 757,852 63
Clearing Members 1,010 0.01 1,010 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 51,512 0.41 51,512 74
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 106,872 0.85 106,872 99
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 712,819 5.66 712,819 22
Individuals holding nominal share capital up to Rs. 1 lakh 4,110,542 32.65 1,969,209 16,809
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,757,654 45.74 3,599,274 17,071
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,589,000 100.00 10,352,700 17,082

Company Background

Lactose (India) LtdPharmaceuticals - Indian - Bulk Drugs

  • Lactose (India) Ltd
  • BSE Code : 2283.0
  • ISIN : INE058I01013

  • Incorporation Year

    1991

  • Registered Office

    Survey No 6
    Village Poicha (Rania) Savli, Vadodara,
    Gujarat-391780

  • Telephone

    91-02667-244308/244729

  • FAX

    91-02667-840397

  • Chairman

    Atul Maheshwari

  • Managing Director

    Atul Maheshwari

  • Company Secretary

    Ritesh Pandey.

  • Auditor

    CAS & Co/DMKH & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Lactose (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lactose (India) 103.45 115.01 113.89 21.07 17.77
Abbott India 30,147.65 6,097.18 5,848.91 48.01 44.71
Astrazeneca Phar 7,992.35 1,330.33 1,295.53 206.04 33.26
P & G Health Ltd 5,030.35 1,166.89 1,151.26 35.30 39.76
Glaxosmi. Pharma 2,758.30 3,530.73 3,407.25 54.85 44.44
Cipla 1,478.50 17,645.00 16,574.34 25.35 20.10
Amrutanjan Healt 692.60 437.58 421.23 40.60 20.84
Guj. Themis Bio. 269.15 174.19 169.82 55.72 44.82
Fermenta Biotec. 258.90 315.24 307.09 24.54 4.10
Bliss GVS Pharma 112.05 638.96 605.46 25.64 11.19
Ambalal Sarabhai 35.20 11.70 3.81 15.04 1.92